Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu

31 January 2024

REPROCELL's clinical stem cells manufacturing partner Histocell has obtained AEMPS authorisation and GMP certification for its new manufacturing plant, that is located in Larrabetzu, Spain. Histocell's manufacturing plant  produces cell therapy and associated biological medicinal products.

Read Histocell's press release (offsite )

See REPROCELL's GMP MSC production servicespage for more information.

---

Corporate news by tag

1. 3D Cell Culture
2. Clinical Capabilities
3. Drug Discovery
4. Genomic Services
5. GMP
6. Human Tissue Samples
7. Human Tissue Testing
8. Life Sciences
9. Master Cell Banks
10. Precision Medicine
11. Product Catalog
12. Regenerative Medicine
13. Stem Cells
14. Volunteer Registry

 Corporate news archive